glp 1 agonist alzheimer Popular obesity drug fails in hotly anticipated Alzheimer's trials | Science The mechanism and efficacy of

Zepbound is FDA-approved for chronic weight management and moderate to severe obstructive sleep apnea in adults with obesity

Sustainable weight loss often requires a personalized, multi-factor approach: Weight gain is influenced by hormones, insulin resistance, sleep, stress, and muscle lossnot just appetite

Manufacturers obtained pediatric exclusivities on 2 products after approval, which added 6 months to the existing patent expiration dates

However, it remains uncertain whether the doses used for diabetes management achieve sufficient central nervous system penetration to produce clinically meaningful neuroprotective effects

Zhang XP, Hintze TH